Ainos regains Nasdaq compliance

Ainos (AIMD) has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The compliance confirmation comes as Ainos gains momentum across its AI Nose platform, with strategic deployments, commercial partnerships, and a 90-day execution plan aimed at enabling large-scale commercialization by 2026. Building toward its 2026 scale-up, Ainos will focus on the following near-term priorities: Complete pilot deployment of approximately 1,400 AI Nose units with ASEH and initiate Phase 1 expansion to approximately 5,000 units. With Kenmec, exhibit the AI Nose integrated ugo robot at Automation Taipei, to be held August 20-23 in Taiwan. Drive SmellTech-as-a-Service as a subscription-based revenue model for AI Nose deployments and Smell ID services. Enhance SLM performance through broad-scale validation and expanded real-world testing. Pursue additional strategic partnerships in Asia and Europe for technology licensing and regional commercialization.